Meet the Team
Claudia Kemper, Ph.D.
Dr. Kemper is a Senior Investigator and Section Chief at the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH) in Bethesda, Maryland.
Dr. Kemper received her Ph.D. in 1998 from the Bernhard-Nocht-Institute for Tropical Medicine, in Germany, and joined John Atkinson’s laboratory as a postdoctoral fellow at Washington University (Saint Louis) in 1999. Here, she discovered that the complement regulator CD46 is a key checkpoint in human Th1 induction. Dr. Kemper moved to King’s College London in 2008, where her group discovered the intracellularly active complement (the complosome) which serves non-canonical roles in cell biology, including the regulation of key metabolic pathways, mitochondrial dynamics, and gene transcription. Her group further showed that complosome perturbations are associated with a range of human diseases, including primary immune deficiency, and arthritic and cardiovascular disease.
Dr. Kemper is the recipient of a Wellcome Trust Investigator Award, the Merit Award for Excellence in Science from the International Complement Society, two Orloff Awards in Science from the NHLBI/NIH. She is an elected member of the Henry Kunkel Society, serves on the Scientific Board of Apellis, Inc., is the current NHLBI representative of the Women Scientists Advisors (WSA), a current member of the American Association of Immunologists (AA) Committee on the Status of Women, the Head of Admission of the NIH-OXCAM Scholars Program, and the sitting President of the International Complement Society.